BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3829005)

  • 1. Role of antitumor activity of alveolar macrophages in lung cancer patients.
    Kuda T; Yasumoto K; Yano T; Nakahashi H; Sugimachi K; Nomoto K
    Cancer Res; 1987 Apr; 47(8):2199-202. PubMed ID: 3829005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of macrophages in lung cancer patients with special reference to location of macrophages.
    Nakahashi H; Yasumoto K; Nagashima A; Yaita H; Takeo S; Motohiro A; Furukawa T; Inokuchi K; Nomoto K
    Cancer Res; 1984 Dec; 44(12 Pt 1):5906-9. PubMed ID: 6498848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of tumor-associated macrophages in lung cancer.
    Takeo S; Yasumoto K; Nagashima A; Nakahashi H; Sugimachi K; Nomoto K
    Cancer Res; 1986 Jun; 46(6):3179-82. PubMed ID: 3698034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of rat alveolar macrophages to the tumoricidal state in the presence of progressively growing pulmonary metastases.
    Sone S; Fidler IJ
    Cancer Res; 1981 Jun; 41(6):2401-6. PubMed ID: 7237438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of in vitro tumoricidal activity in alveolar macrophages and monocytes from patients with lung cancer.
    Thomassen MJ; Wiedemann HP; Barna BP; Farmer M; Ahmad M
    Cancer Res; 1988 Jul; 48(14):3949-53. PubMed ID: 2838166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients.
    Droemann D; Goldmann T; Tiedje T; Zabel P; Dalhoff K; Schaaf B
    Respir Res; 2005 Jul; 6(1):68. PubMed ID: 16004610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-dependent cellular cytotoxicity in blood monocytes and alveolar macrophages in patients with lung cancer.
    McLennan G; Gill PG; De Young NJ
    J Natl Cancer Inst; 1985 Jul; 75(1):23-7. PubMed ID: 3859693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of arginase activity in alveolar macrophages from patients with lung cancer].
    Yang H; Li G; Huang S; Qu S
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):84-6. PubMed ID: 9868039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
    Sone S; Tsubura E
    J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic activity of human pulmonary alveolar macrophages.
    Kan-Mitchell J; Hengst JC; Kempf RA; Rothbart RK; Simons SM; Brooker AS; Kortes VL; Mitchell MS
    Cancer Res; 1985 Jan; 45(1):453-8. PubMed ID: 3965151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human alveolar macrophages: wheat germ agglutinin-dependent tumor cell killing.
    Ogawara M; Sone S; Ogura T
    Jpn J Cancer Res; 1987 Mar; 78(3):288-95. PubMed ID: 3106285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alveolar macrophage and blood monocyte function in lung cancer.
    Hosker HS; Corris PA
    Cancer Detect Prev; 1991; 15(2):103-6. PubMed ID: 2032250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Observation on the activity of superoxide dismutase and catalase of alveolar macrophage in patients with lung cancer].
    Tang ZP
    Zhonghua Jie He He Hu Xi Za Zhi; 1991 Aug; 14(4):213-5, 255. PubMed ID: 1666343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemiluminescent measurements of alveolar macrophages in sarcoidosis patients].
    Winsel K; Christ R; Eckert H; Renner H; Unger U; Grollmuss H
    Z Erkr Atmungsorgane; 1987; 169(1):23-32. PubMed ID: 3673126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and morphological differences between human alveolar and interstitial macrophages.
    Fathi M; Johansson A; Lundborg M; Orre L; Sköld CM; Camner P
    Exp Mol Pathol; 2001 Apr; 70(2):77-82. PubMed ID: 11263950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of pleural cavity macrophages and its regulation by pleural cavity lymphocytes in patients with lung cancer.
    Nagashima A; Yasumoto K; Nakahashi H; Takeo S; Yano T; Nomoto K
    Cancer Res; 1987 Oct; 47(20):5497-500. PubMed ID: 3652051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.
    Chen JJ; Yao PL; Yuan A; Hong TM; Shun CT; Kuo ML; Lee YC; Yang PC
    Clin Cancer Res; 2003 Feb; 9(2):729-37. PubMed ID: 12576442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of alveolar macrophages in tumor-bearing rats: tumoricidal properties of carrageenan-activated macrophages.
    Bijma AM; Stehmann TE; Weijma IM; Kort WJ
    Invasion Metastasis; 1988; 8(6):364-73. PubMed ID: 3225148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.
    Keller SM; Vangel MG; Wagner H; Schiller JH; Herskovic A; Komaki R; Marks RS; Perry MC; Livingston RB; Johnson DH;
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):130-7. PubMed ID: 15224032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.